Societal Cost of Opioid Use in Symptomatic Knee Osteoarthritis Patients in the United States.

Jamie L HuizingaElizabeth E StanleyJames K SullivanShuang SongDavid John HunterA David PaltielTuhina NeogiRobert R EdwardsJeffrey N Katz Elena Losina

Published in: Arthritis care & research (2021)

Lost productivity, diversion, and criminal justice costs comprise about half of opioid-related costs generated by the USA SKOA population. Reducing chronic opioid use may lead to a meaningful reduction in societal costs that can be used for other public health causes.

Keyphrases

knee osteoarthritis
public health
end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
climate change
peritoneal dialysis
prognostic factors
patient reported outcomes
robot assisted
mental illness
mental health
minimally invasive
patient reported